A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 3,791 shares of BMY stock, worth $213,130. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,791
Previous 3,725 1.77%
Holding current value
$213,130
Previous $154,000 27.27%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $2,617 - $3,415
66 Added 1.77%
3,791 $196,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $66,452 - $87,486
-1,651 Reduced 30.71%
3,725 $154,000
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $7,628 - $8,649
159 Added 3.05%
5,376 $291,000
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $30,590 - $36,503
-631 Reduced 10.79%
5,217 $267,000
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $110,685 - $123,763
-1,912 Reduced 24.64%
5,848 $339,000
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $76,770 - $85,241
-1,205 Reduced 13.44%
7,760 $496,000
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $149,293 - $169,332
2,272 Added 33.95%
8,965 $621,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $41,224 - $48,816
602 Added 9.88%
6,693 $481,000
Q3 2022

Oct 26, 2022

BUY
$0.13 - $76.84 $11 - $6,685
87 Added 1.45%
6,091 $432,000
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $76,105 - $83,819
-1,048 Reduced 14.86%
6,004 $461,000
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $56,500 - $67,748
-919 Reduced 11.53%
7,052 $514,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $11,530 - $13,441
215 Added 2.77%
7,971 $496,000
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $76,329 - $89,409
1,290 Added 19.95%
7,756 $458,000
Q2 2021

Jul 27, 2021

BUY
$61.91 - $67.42 $61 - $67
1 Added 0.02%
6,466 $431,000
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $26,050 - $29,298
439 Added 7.29%
6,465 $407,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $36,433 - $41,286
631 Added 11.7%
6,026 $373,000
Q3 2020

Oct 20, 2020

BUY
$57.43 - $63.64 $286,920 - $317,945
4,996 Added 1252.13%
5,395 $324,000
Q2 2020

Jul 02, 2020

SELL
$54.82 - $64.09 $13,156 - $15,381
-240 Reduced 37.56%
399 $23,000
Q1 2020

Apr 01, 2020

BUY
$46.4 - $67.43 $4,176 - $6,068
90 Added 16.39%
639 $35,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $10,038 - $13,094
204 Added 59.13%
549 $35,000
Q3 2019

Oct 09, 2019

SELL
$42.77 - $50.71 $5,731 - $6,795
-134 Reduced 27.97%
345 $17,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $1,918 - $2,121
43 Added 9.86%
479 $25,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $2,194 - $2,845
-45 Reduced 9.36%
436 $24,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $39,295 - $44,322
-712 Reduced 59.68%
481 $31,000
Q2 2018

Aug 16, 2018

SELL
$50.53 - $62.98 $303 - $377
-6 Reduced 0.5%
1,193 $68,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $4,553 - $5,242
-76 Reduced 5.96%
1,199 $77,000
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $6,653 - $7,253
111 Added 9.54%
1,275 $79,000
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $4,197 - $4,844
76 Added 6.99%
1,164 $75,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,088
1,088 $62,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.